OnKure Therapeutics, Inc. ( OKUR) - Key Metrics
OKUR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.31 | -$0.21 | -$0.21 |
| 2026Q1 | $0 | -$1.11 | -$0.95 | -$0.95 |
| 2025Q4 | $0 | -$1 | -$0.85 | -$0.85 |
| 2025Q3 | $0 | -$1.09 | -$0.97 | -$0.97 |
| 2025Q2 | $0 | -$1.14 | -$0.98 | -$0.98 |
OKUR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.68 |
| 2026Q1 | 0% | -0.93 |
| 2025Q4 | 0% | -0.73 |
| 2025Q3 | 0% | -0.63 |
| 2025Q2 | 0% | -0.52 |
OKUR
Price: $3.94
52 week price:
Earnings Per Share: -3.11 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 166.0 million